-
2008
28 August 2008: Announcement no. 2, 2008: Zealand Pharma today announced that Dr. David H...
-
Product Pipeline
Zealand's Pipeline comprises 1 compound in phase III, 2 compounds in phase II, 3 compounds ...
ZP1846 Publications
Petersen, Y.M., Thorkildsen, C., Petersen, J.S. and Kjølbye, A.L:
ZP 1846, a Novel Potential Candidate for the Treatment of Chemotherapy-Induced Diarrhea
Abstract for Course: Gastrointestinal Response to Injury - Canada 2007.
3rd October – 6th October 2007, Montebello, Quebec, Canada
Petersen, Y.M., Thorkildsen, C., Petersen, J.S. and Kjølbye, A.L:
ZP 1846, a Novel Potential Candidate for the Treatment of Chemotherapy-Induced Diarrhea.
Poster: Multinational Association of Supportive Care in Cancer (MASCC) - 20th International Symposium «Supportive Care in Cancer». St.Gallen, Switzerland. 28th - 30th June 2007.
Support Care Cancer, 2007, 15, 772-773
Petersen, Y.M., Jepsen, T., Thorkildsen, C., Larsen, B.D., Petersen, J.S. and Kjølbye, A.:
ZP 1846, a novel stable, high efficacy glucagon-like peptide 2 mimetic, stimulates small intestinal growth and prevents 5-fluorouracil-induced small intestinal injury in c57bl mice.
Annual meeting - Pharmacology of Membrane Proteins: from molecule to clinic. Joint meeting between The German Pharmacological Society and The Danish Society of Pharmacology and Toxicology, 21-22 June 2007, Copenhagen, Denmark
Poster Abstract No. 19, Meeting Programme p 40
Poster
Petersen, Y. M., Jepsen, T., Thorkildsen, C., Larsen, B.D., Petersen, J.S. and Kjølbye, A.:
ZP 1846, a novel stable, high efficacy glucagon-like peptide 2 mimetic, stimulates small intestinal growth and prevents 5-fluorouracil-induced small intestinal injury in C57BL mice.
Abstract for 14th United European Gastroenterology Week (UEGW 2006), 21-25 October 2006, Berlin, Germany. Presentation OP-G-213
Gut, 2006, 55, Supplement No. V, A48
Petersen, Y.M., Larsen, B.D., and Petersen, J.S.:
[Gly2]GLP-2 Administration Both Prior To And Concurrently With Chemotherapy Inhibits Small Intestinal Atrophy And Attenuates Body Weight Loss in Mice.
Poster at American Gastroenterological Association - Digestive Diseases Week. Chicago, Illinois, USA, May 12th-19th 2005.
Poster presentation
Petersen, Y.M., Larsen, B.D. and Petersen, J.S.:
[Gly2]GLP-2 inhibits chemotherapy-induced small intestinal atrophy and body weight loss in mice.
Poster B6 for Dansk Farmakologi 2005, 19 Januar, 2005, SDU, Odense, Denmark, Abstract
Poster presentation
Tip a friend
Fill in the form below to tip a friend about this page.
Subscribe
When this page is updated you will be updated by e-mail.